Peptide Protocols
This section provides educational overviews of commonly researched peptides and wellness compounds, including how researchers typically approach starting amounts, progression strategies, duration of use, potential side effects, and important safety considerations.
See Sources Below ⤵️
SOURCES:
* SURPASS Clinical Trial Program
* SURMOUNT Clinical Trial Program
* New England Journal of Medicine
* National Center for Biotechnology Information (NCBI)
* FDA Safety Communications Regarding NAD+ Products
* Circulation (American Heart Association)
* International Journal of Obesity
* Journal of Endocrinology and Metabolism
* Novo Nordisk Clinical Trial Publications
* CagriSema Phase 2 and Phase 3 Studies
* Journal of Physiology Paris
* Russian Academy of Sciences Publications
* PubMed
* The Lancet